NASDAQ: HHS
Harte Hanks Inc Stock

$5.45+0.01 (+0.18%)
Updated Feb 6, 2025
HHS Price
$5.45
Fair Value Price
$8.54
Market Cap
$39.72M
52 Week Low
$4.85
52 Week High
$8.87
P/E
-1.33x
P/B
1.89x
P/S
0.29x
PEG
N/A
Dividend Yield
N/A
Revenue
$187.60M
Earnings
-$29.84M
Gross Margin
68.9%
Operating Margin
-21.27%
Profit Margin
-15.9%
Debt to Equity
4.14
Operating Cash Flow
-$3M
Beta
0.69
Next Earnings
Mar 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

HHS Overview

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company provides strategic guidance to help clients to plan and execute omni-channel marketing programs; audience identification, profiling, segmentation and prioritization, predictive modeling, and data strategy services; data hygiene and cleansing services; print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice services; Website and app development, e-commerce enablement, database building and management, platform architecture creation, and marketing automation services; and outsourcing marketing operations solutions. It also offers customer experience management services comprising interact and resolve consumer concerns across hardware and software platforms, healthcare benefit plans, and recalls or a myriad of other customer service issues; CRM and digital transformation solutions to create meaningful customer interactions by connecting content between agent or AI-driven interfaces and web-based self-help tools and community forums; and intelligence-based B2B solutions that understand audiences and their behaviors, and then inspire and drive action to deliver results. In addition, the company provides product, print-on-demand, and mail fulfillment solutions, such as printing on demand, managing product recalls, and distributing literature and promotional products; custom solutions to engage audiences, target customers, support conferences, and appreciate employees; and third-party logistics and freight optimization services. It primarily serves B2B, consumer brand, financial services, retail, and healthcare vertical markets. Harte Hanks, Inc. was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HHS's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
D
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Conglomerate

Industry Rating
C
HHS
Ranked
#10 of 16

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$40.03B
$80.89B
$330.82B
View Top Conglomerate Stocks

Be the first to know about important HHS news, forecast changes, insider trades & much more!

HHS News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HHS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HHS ($5.45) is undervalued by 36.2% relative to our estimate of its Fair Value price of $8.54 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HHS ($5.45) is significantly undervalued by 36.2% relative to our estimate of its Fair Value price of $8.54 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HHS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more HHS due diligence checks available for Premium users.

Valuation

HHS fair value

Fair Value of HHS stock based on Discounted Cash Flow (DCF)

Price
$5.45
Fair Value
$8.54
Undervalued by
36.20%
HHS ($5.45) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HHS ($5.45) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HHS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HHS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-1.33x
Industry
16.87x
Market
31.69x

HHS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.89x
Industry
5.83x
HHS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HHS's financial health

Profit margin

Revenue
$47.6M
Net Income
$142.0k
Profit Margin
0.3%
HHS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HHS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$108.1M
Liabilities
$87.1M
Debt to equity
4.14
HHS's short-term assets ($53.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HHS's short-term assets ($53.82M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HHS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HHS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
-$1.9M
Financing
-$163.0k
HHS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HHS vs Conglomerate Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HHSC$39.72M+0.18%-1.33x1.89x
EFSH$2.78M-5.06%-0.00x-0.11x
TUSKC$148.23M-1.60%-0.75x0.55x
RCMTB$153.92M+1.00%10.13x5.12x
NNBRD$160.83M-3.30%-2.93x1.51x

Harte Hanks Stock FAQ

What is Harte Hanks's quote symbol?

(NASDAQ: HHS) Harte Hanks trades on the NASDAQ under the ticker symbol HHS. Harte Hanks stock quotes can also be displayed as NASDAQ: HHS.

If you're new to stock investing, here's how to buy Harte Hanks stock.

What is the 52 week high and low for Harte Hanks (NASDAQ: HHS)?

(NASDAQ: HHS) Harte Hanks's 52-week high was $8.87, and its 52-week low was $4.85. It is currently -38.56% from its 52-week high and 12.37% from its 52-week low.

How much is Harte Hanks stock worth today?

(NASDAQ: HHS) Harte Hanks currently has 7,288,983 outstanding shares. With Harte Hanks stock trading at $5.45 per share, the total value of Harte Hanks stock (market capitalization) is $39.72M.

Harte Hanks stock was originally listed at a price of $123.33 in Dec 31, 1997. If you had invested in Harte Hanks stock at $123.33, your return over the last 27 years would have been -95.58%, for an annualized return of -10.91% (not including any dividends or dividend reinvestments).

How much is Harte Hanks's stock price per share?

(NASDAQ: HHS) Harte Hanks stock price per share is $5.45 today (as of Feb 6, 2025).

What is Harte Hanks's Market Cap?

(NASDAQ: HHS) Harte Hanks's market cap is $39.72M, as of Feb 8, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Harte Hanks's market cap is calculated by multiplying HHS's current stock price of $5.45 by HHS's total outstanding shares of 7,288,983.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.